These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 14609009

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS, Attenburrow MJ, Cowen PJ.
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [Abstract] [Full Text] [Related]

  • 7. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
    Seifritz E, Müller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U, Moore P, Holsboer-Trachsler E.
    J Psychiatr Res; 1997 Sep; 31(5):543-54. PubMed ID: 9368196
    [Abstract] [Full Text] [Related]

  • 8. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
    Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RW.
    Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants.
    Kuepper Y, Bausch S, Iffland J, Reuter M, Hennig J.
    Psychoneuroendocrinology; 2006 Nov; 31(10):1200-7. PubMed ID: 17123742
    [Abstract] [Full Text] [Related]

  • 11. Citalopram challenge in social anxiety disorder.
    Shlik J, Maron E, Tru I, Aluoja A, Vasar V.
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.
    Schüle C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G.
    Psychoneuroendocrinology; 2004 Feb; 29(2):185-200. PubMed ID: 14604600
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [Abstract] [Full Text] [Related]

  • 16. The citalopram challenge test in patients with major depression and in healthy controls.
    Kapitany T, Schindl M, Schindler SD, Hesselmann B, Füreder T, Barnas C, Sieghart W, Kasper S.
    Psychiatry Res; 1999 Nov 08; 88(2):75-88. PubMed ID: 10622344
    [Abstract] [Full Text] [Related]

  • 17. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ, Forsling M, Bond AJ.
    Int Clin Psychopharmacol; 1998 Jan 08; 13(1):23-32. PubMed ID: 9988364
    [Abstract] [Full Text] [Related]

  • 18. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER, Owen JA, Hudson RW, Delva NJ.
    Psychopharmacology (Berl); 2009 Nov 08; 207(1):27-34. PubMed ID: 19662384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.